NASDAQ:APEN
Delisted
Lpath Inc Stock News
$10.00
+0 (+0%)
At Close: Jun 30, 2023
Buy-rated Boston Scientific's $615 million takeover of Apollo Endosurgery is a positive, says Needham
12:00pm, Tuesday, 29'th Nov 2022
Boston Scientific Corp.'s BSX, +0.88% $615 million acquisition of Apollo Endosurgery Inc. APEN, +65.50% announced earlier is complementary to the former's endoscopy franchise, as it leverages its gast
Apollo Endosurgery Stock Soars on Buyout Buzz
10:50am, Tuesday, 29'th Nov 2022
Apollo Endosurgery Inc (NASDAQ:APEN) stock is soaring, up 63.4% at $9.80 at last glance, after news that Boston Scientific Corp (BSX) will acquire the medical equipment name for $417 million.
Boston Scientific to acquire Apollo Endosurgery for $615 million in cash
07:13am, Tuesday, 29'th Nov 2022
Boston Scientific Corp. BSX, -0.82% said Tuesday it has agreed to acquire Apollo Endosurgery Inc. APEN, for $10 a share, or about $615 million in cash. The news sent Apollo's stock, which closed Monda
Apollo Endosurgery, Inc. (APEN) Q3 2022 Earnings Call Transcript
10:18pm, Tuesday, 01'st Nov 2022
Apollo Endosurgery, Inc. (NASDAQ:APEN ) Q3 2022 Earnings Conference Call November 1, 2022 4:30 PM ET Company Participants Matt Kreps – Investor Relations Chas McKhann – Chief Executive Officer Jef
Apollo Endosurgery to Report Third Quarter Results on November 1, 2022
08:00am, Tuesday, 18'th Oct 2022
AUSTIN, TX / ACCESSWIRE / October 18, 2022 / Apollo Endosurgery, Inc. ("Company" or "Apollo") (NASDAQ:APEN), a global leader in next-generation minimally invasive medical devices for gastrointestinal
Apollo Endosurgery, Inc. (APEN) CEO Chas McKhann on Q2 2022 Results - Earnings Call Transcript
02:37am, Monday, 08'th Aug 2022
Apollo Endosurgery, Inc. (NASDAQ:APEN ) Q2 2022 Earnings Conference Call August 2, 2022 4:30 PM ET Company Participants Matt Kreps - Investor Relations Chas McKhann - Chief Executive Officer Jeff Blac
Apollo Endosurgery: Collect Shares At A Discount Following Q2 Earnings
04:45am, Thursday, 04'th Aug 2022
Apollo Endosurgery came in with another strong quarter of top-line growth whilst growing gross margins on the same. The company saw substantial growth in each of its key segments, coupled with regulat
Apollo Endosurgery to Report Second Quarter Results on August 2, 2022
08:00am, Thursday, 21'st Jul 2022
AUSTIN, TX / ACCESSWIRE / July 21, 2022 / Apollo Endosurgery, Inc. ("Company" or "Apollo") (NASDAQ:APEN), a global leader in next-generation minimally invasive medical devices for gastrointestinal and
Hot Penny Stocks to Watch Right Now? 3 For Your July List
04:15pm, Wednesday, 13'th Jul 2022
Which penny stocks are you watching right now? The post Hot Penny Stocks to Watch Right Now?
Apollo Endosurgery's New Obesity Endoscopic Systems Receive FDA Nod
10:31am, Wednesday, 13'th Jul 2022
Apollo Endosurgery Inc (NASDAQ: APEN) announced the marketing authorization of the Apollo ESG, Apollo ESG Sx, Apollo REVISE, and Apollo REVISE Sx Systems through the FDA De Novo Classification proc
This Analyst Thinks Apollo Endosurgery's Valuation 'Does Not Assign Full Value' - Read Why
04:05pm, Wednesday, 04'th May 2022
Stephens has reiterated an Overweight rating for Apollo Endosurgery Inc (NASDAQ: APEN) while increasing the price target from $8 to $9. "In our opinion, APEN's valuation does not assign full value
Apollo Endosurgery, Inc. (APEN) CEO Chas McKhann on Q1 2022 Results - Earnings Call Transcript
11:06pm, Tuesday, 03'rd May 2022
Apollo Endosurgery, Inc. (NASDAQ:APEN ) Q1 2022 Earnings Conference Call May 3, 2022 4:30 PM ET Company Participants Matt Kreps - Investor Relations Chas McKhann - Chief Executive Officer Jeff Black -
Apollo Endosurgery, Inc. (APEN) Reports Q1 Loss, Tops Revenue Estimates
08:19pm, Tuesday, 03'rd May 2022
Apollo Endosurgery, Inc. (APEN) delivered earnings and revenue surprises of 0% and 6.18%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Apollo Endosurgery to Report First Quarter Results on May 3, 2022
08:45am, Wednesday, 13'th Apr 2022
AUSTIN, TX / ACCESSWIRE / April 13, 2022 / Apollo Endosurgery, Inc. ("Company" or "Apollo") (Nasdaq:APEN), a global leader in next-generation minimally invasive medical devices for gastrointestinal an
Apollo Endosurgery up 17% after CFO adds shares
07:15pm, Wednesday, 02'nd Mar 2022 Seeking Alpha
Apollo Endosurgery <> jumps after CFO Jeffrey G